SULIDAPA MXR 10/500 (Dapagliflozin (10mg) + Metformin (500mg))

Sulidapa MXR 10mg/500mg Tablet is formulated as a combination therapy for managing type 2 diabetes mellitus. This medication plays a crucial role in regulating elevated blood glucose levels associated with diabetes, thus reducing the risk of severe complications related to the condition, including the potential onset of cardiovascular diseases. It is advised to administer this tablet alongside food for optimal efficacy. Consistency in dosage is important; therefore, taking it at the same time each day can enhance adherence to the treatment schedule. Dosage recommendations will be determined by your healthcare provider, and it is essential to consult them before discontinuing the medication, as abrupt cessation may lead to elevated blood sugar levels, subsequently increasing the risk of serious issues such as renal impairment and vision loss. It is important to understand that this tablet is part of a comprehensive management plan, which should also include a nutritious diet, regular physical activity, and weight management as outlined by your healthcare provider. While using this medication, staying adequately hydrated is advised to prevent dehydration, particularly since gastrointestinal side effects such as nausea, vomiting, and diarrhea may occur. Some individuals may experience genital fungal infections; practicing good hygiene can mitigate this risk. Prior to starting this treatment, inform your physician of any pre-existing kidney or liver conditions, urinary tract infections, or if you are using diuretics. Pregnant or lactating individuals should also seek medical advice before initiating therapy. Regular monitoring of blood glucose levels is recommended during the course of treatment.